Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-29

FDA Approved: RELEUKO — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for RELEUKO (filgrastim) from Amneal Pharmaceuticals LLC. This reflects regulatory action on a supplemental submission f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RELEUKO (FILGRASTIM)

Snippet

SUPPL AP for RELEUKO (FILGRASTIM)